HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- Study results renew debate over value of mammography
-
- ‘The anemia of chronic disease’: An outmoded diagnosis H. Franklin Bunn, MD
- ASCO elects seven to leadership roles
- Blood cancer center opens in Pittsburgh
- Center announces awards, appointments
- Foundation offers survivorship toolkit
- Oral contraceptive use cited as a risk factor of VTE after hip arthroscopy
- Physicians receive research grants
- FDA approves Eliquis to prevent stroke, blood clots in AF
-
- FDA approves Promacta for patients with chronic HCV, thrombocytopenia
- Novel drug reduced tumors, bone pain in advanced prostate cancer
- Antiviral therapy may prevent HCC development in patients with chronic HCV
- Arsenic trioxide effective as first-line treatment for elderly patients with newly diagnosed AML
- Aspirin regimen increased survival in elderly patients with colon cancer
- Blood transfusions increased risk for death in MI patients
- Cancer centers collaborate to talk about TKI therapy in thyroid cancer
- FDA approves breast cancer detection device
-
- Genetic biomarker identified in bladder cancer tumors
- H. pylori infection increased risk for colonic neoplasms
- Higher carotenoid levels may reduce breast cancer risk
- Ibrutinib induced significant response in B-cell malignancies
- Multivitamins show promise in cancer prevention in middle-aged men
- Novel induction regimen associated with favorable outcomes in HNSCC
- Rates of two HPV-related cancers increased, HPV vaccination low
- Regorafenib prolonged survival in patients with metastatic colorectal cancer
-
- Retinoblastoma, PTEN may predict DCIS progression to invasive breast cancer
- Right-sided colon polyps with advanced pathology smaller than lesions in left colon
- Simple risk score predicted stent thrombosis
- SCCIS of ear treated with Mohs micrographic surgery occurred primarily in men
- Statins reduced heart failure risk during anthracycline chemotherapy
- Survivors of pediatric embryonal tumors functioned well several years after diagnosis, treatment
- Tumor volume, metabolism predicted survival in diffuse large B-cell lymphoma
- Dabigatran shows promise in unselected cohort
-
- Elastic compression stockings failed to prevent post-thrombotic syndrome
- Metformin may protect against hepatocellular carcinoma
- Patients with congenital neutropenia exhibit RUNX1 mutations before AML development
- Pomalidomide, low-dose dexamethasone significantly increased survival in multiple myeloma
- Radiation therapy may be unnecessary for some patients with early-stage Hodgkin’s lymphoma
- Acid-reducing medications should be used cautiously when combined with erlotinib Asif Siddiqui, PharmD, BCOP